Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 September 2021 | Story Michelle Nöthling | Photo Supplied
Simoné du Preez


“A community needs a culture, and a culture needs a language.” Pause a moment and consider these words of Simoné du Preez. 

How do we express our beliefs, values, customs, and norms, if not through language? The same is true for the Deaf – who are a minority cultural group in its own right. “Sign Language is the language in which the Deaf community laughs, cries, learns, and loves,” Simoné, a South African Sign Language (SASL) interpreter at the University of the Free State (UFS), points out. “Without it, no expression – and no cultural expression – can take place.”

Simoné’s passion for SASL was ignited while studying BA Language Practice at the UFS. Taking SASL as a main subject, she fell in love with the language, the culture, the history, and its people. Simoné then went on to do her honour’s degree in Language Practice, with specialisation in SASL Interpreting, and she never looked back. During her seven years as an interpreter at the UFS, Simoné still feels humbled by the student community she serves. “I get to learn so much from students from every walk of life, studying anything from Education to the Arts to Actuarial Sciences.” She enjoys seeing what Deaf students are capable of and is also “proud to be a part of their success stories.”

She not only has a soft spot for our students, but also for the Department of SASL and Deaf Studies that has helped shape her into the interpreter she is today. Simoné adds that she loves working with the Centre for Universal Access and Disability Support (CUADS). “It’s amazing to see what lengths Martie Miranda and her team are willing to go through in order to achieve equity and equality for our students with disabilities. I am humbled and honoured to be able to play a small role in their big plan.”

Always pushing herself to improve, Simoné has now set herself the goal of becoming a SASL interpreter accredited by the South African Translators’ Institute (SATI). It is immensely important for Simoné that the Deaf community has access to all information at all times – equal to that of a hearing person. The recognition of SASL as an official language in South Africa is vital to actualising this. Simoné underscores the fact that without this recognition, the Deaf are being silenced. “Their voices are just as important as every other person’s. It is time that we listen to what the Deaf community has to say.”


News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept